Jupiter Neurosciences (NASDAQ:JUNS) will present at the 3rd Annual DealFlow Discovery Conference on January 28-29, 2026 at The Borgata Hotel, Casino & Spa in Atlantic City, NJ.Christer Rosén, Chairman and CEO, will deliver a company presentation and is available for one-on-one investor meetings. Investors can request an investor pass at no cost to attend. More information about the company is available at the company website.

Transformer-based biosecurity layer embeds directly into foundation models, using Lunai's proprietary toxicology and in-vivo datasets to detect and prevent creation of previously unknown threat agents in real time.. SACRAMENTO, Calif., Jan. 27, 2026/ PRNewswire/-- As global attention intensifies around the dual-use risks of advanced artificial...

Critical Metals Corp (NASDAQ: CRML) will deploy a fully autonomous Nexus 20 communications tower and integrated drone system at its Tanbreez rare earth project in Greenland, with deployment scheduled for May 2026. The Nexus 20 is custom-engineered for Arctic conditions and will provide continuous radio and emergency communications, 360-degree optical surveillance, and an autonomous drone remotely operated from Perth for real-time imaging and geological reconnaissance. Critical Metals will also receive a fully integrated medical, emergency, and accommodation site package fabricated in Thailand to support remote field teams. The system is intended to improve operational safety, accelerate exploration, and increase transparency for investors.

WEX (NYSE: WEX) introduced a WEX Fleet card with built-in EV payment capabilities that unifies payments for fuel and public EV charging into one card, one account, one invoice. The card embeds RFID for tap-to-charge and runs on WEX’s proprietary closed-loop fleet network, providing unified reporting, purchase controls via DriverDash, and a single credit line. It supports over 175,000 WEX-accepting public charging ports and works at > 90% of U.S. gas stations that accept WEX cards. The feature is available today for eligible fleet customers and can be enabled immediately or at card renewal.

D-Wave (NYSE: QBTS) announced a $10 million, two-year enterprise Quantum Computing as a Service (QCaaS) agreement with a leading Fortune 100 company to collaborate on developing and deploying multiple quantum-powered applications.The company described the contract as a milestone for annealing quantum computing enterprise adoption and positioned it as an endorsement of D-Wave's production-grade quantum technology. The release also invited investors and stakeholders to Qubits 2026 on January 27–28, 2026 in Boca Raton, Florida for further details.

Ashland Capital Partners announced the sale of KBK Industries, a Houston-based manufacturer of fiberglass and steel tanks and separation equipment, concluding a 19-year partnership that began with Ashland's 2006 acquisition.During ownership, Ashland scaled KBK's manufacturing capabilities and preserved its quality focus. Ashland reported an annual IRR of 45.5% and a MOIC of 118x on its equity investment in KBK, and said the sale reflects long-term value creation supported by CEO Steven White and founder Bill Baalmann. Ashland was supported by long-time partner Main Street Capital Corp (NYSE: MAIN) on the transaction.

Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce the follow-on award of several contracts

BD (NYSE: BDX) set Feb 5, 2026 as the record date for the spin-off of its Biosciences & Diagnostic Solutions business and expects to combine the spun-off unit with Waters (NYSE: WAT) via a Reverse Morris Trust on Feb 9, 2026, subject to customary closing conditions.Under the terms, BD will receive $4 billion cash, and BD shareholders will receive Waters common stock representing 39.2% of the combined company on a fully diluted basis; Waters shareholders will own 60.8%.Shares will trade with due bills starting Feb 5 and trade ex-distribution after closing; BD received a favorable IRS private letter ruling.

Waters (NYSE: WAT) shareholders approved issuing Waters common stock to shareholders of Becton, Dickinson and Company (NYSE: BDX) for the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters, with preliminary voting showing ~99% support.Waters and BD received all required regulatory approvals and BD obtained a favorable IRS Private Letter Ruling on U.S. federal tax matters. The transaction is expected to close on February 9, 2026, subject to customary closing conditions. Waters will release Q4 2025 results and hold a conference call and webcast on February 9, 2026 at 8:30 a.m. ET; a replay will be available through at least March 9, 2026.

INmune Bio (NASDAQ: INMB) CEO David Moss reviewed 2025 progress and outlined 2026 priorities, highlighting clinical and regulatory milestones for two lead programs: CORDStrom for recessive dystrophic epidermolysis bullosa (RDEB) and XPro (XPro1595) for Alzheimer’s disease. Key 2025 items include three commercial pilot-scale manufacturing runs for CORDStrom, a planned MAA submission in mid‑summer 2026 to the UK MHRA and a targeted BLA submission late 2026 to FDA (timelines subject to regulatory feedback). XPro’s Phase 2 MINDFuL showed biomarker‑defined signals (EMACC effect size 0.27) guiding a precision‑medicine registrational path. Cash and equivalents were approximately $27.7M as of Sept 30, 2025, with financing and rebates expected to fund operations through year‑end 2026.

IsoEnergy (NYSE American: ISOU, TSX: ISO) closed a bought deal financing on Jan 27, 2026, selling 3,833,410 common shares at C$15.00 per share for gross proceeds of C$57,501,150, including full exercise of the over-allotment option. The offering was led by Stifel Canada, Canaccord Genuity Corp. and Jett Capital Advisors.Proceeds are expected to fund continued development and further exploration of the company’s mineral properties and for general corporate purposes. The company also anticipates closing a previously announced non-brokered concurrent private placement with NexGen Energy Ltd. on or about the date hereof.

Today, the company announced Phoenix as the site of a new facility for its healthcare division, Concorde Career Colleges. "The momentum created by the strong execution of our North Star strategy is accelerating as we expand into markets that seek the skilled workers our training programs deliver," said Todd Hitchcock, Chief Operating Officer, Universal...

Better Home & Finance Holding Company (NASDAQ: BETR) renewed and amended a $175 million warehouse credit facility with improved terms, including reduced cash deposit requirements, expanded leverage capacity, and higher advance rates on certain non‑GSE loans, which the company says will materially lower equity capital needs. Better.com reaffirmed November 2025 guidance that monthly origination volumes are expected to exceed $1 billion by May 2026 (vs ~$400 million average monthly in Q3 2025) and reiterated expectation of achieving adjusted EBITDA profitability by end of Q3 2026. The release highlights deployment of the Tinman AI platform and growth in partnership channels.

QVC (NASDAQ: QVCGA) announced a slate of new Beauty and Wellness brands joining the platform in 2026, reinforcing those categories as top priorities for the year. New-to-QVC brands include K18, Make Time Wellness, Karma, and Medicine Mama, while additions and exclusive bundles expand offerings from Dyson, TATCHA, Peter Thomas Roth, Dr. Kellyann, Ancient Nutrition, 8Greens, VitaHustle, Pop Sonic, and Vitamix.K18 launched on QVC this month with exclusive deals and bundles across TikTok Shop, QVC.com, and on-air, emphasizing its biomimetic, science-first haircare approach. QVC plans ongoing rollouts of additional brands, launches, and exclusive bundles throughout 2026 and will feature product demos and expert tips via digital, on-air programming, and QVC+ streaming.

Burford Capital (BUR) has set the redemption price for the early repayment of its £175,000,000 5.000% guaranteed bonds due 2026. The Issuer will redeem the outstanding bonds in full on 30 January 2026 (Repayment Date).The Redemption Price payable is 100.290% per £100 principal, plus any accrued but unpaid interest up to (but excluding) the Repayment Date. The price was calculated under Condition 8.3 (Redemption at the Option of the Issuer) and announced further to the issuer's notice dated 15 January 2026.

Snowflake (NYSE: SNOW) on January 27, 2026 launched Energy Solutions — a bundled offering that combines Snowflake governance, partner-built solutions, and industry datasets to unite IT, OT, and IoT data for power, utilities, and oil & gas companies.The launch includes 30+ new partner solutions, a partnership with SAP to combine finance and supply-chain data with operational systems, Snowflake Intelligence natural-language access, and partner features such as CARTO spatial analytics and Itron’s 8,760-hour grid planning analysis that delivers results in hours instead of months.

Charles Schwab (NYSE:SCHW) was named #1 Overall Broker in StockBrokers.com’s 2026 Annual Awards for the second consecutive year, earning top category rankings in Mobile Trading Apps, Advanced Trading, Ease of Use, Customer Service, and High Net Worth Investors. StockBrokers.com’s awards are based on research across 300+ data variables and seven categories. Schwab said it handled about 10% of total US notional trading volume in 2025 and is the leading retail broker by daily average trades. Schwab also won industry awards for Active Trading Desktop Platform and Stock Research.

GEN (Jan 27, 2026) Norton Insights Report: Artificial Intimacy finds mainstream acceptance of AI relationships amid a loneliness surge. 77% of current online daters would consider dating an AI; 59% say falling for an AI is possible. Loneliness affects 81% of people and 89% of Gen Z/Millennials. Dating scams are rising: >17 million scams blocked in Q4 2025 (a 19%+ increase vs 2024). The report warns deeper AI bonds create emotional and financial vulnerabilities while highlighting Norton 360 and other tools to detect fake profiles and block scams.

FAST TRACK GROUP (NASDAQ: FTRK) announced that Fast Track Entertainment signed a Memorandum of Understanding with South Korean agency Leanbranding to serve as the global commercial representative for K-pop group KIIRAS on Jan 27, 2026.The MoU establishes FTE as Leanbranding’s official global commercial representative, marks FTE’s first artist management and representation mandate, and frames future collaboration across live appearances, brand partnerships, and international opportunities beginning in Southeast Asia.Management said the scalable, engagement-driven partnership could contribute a substantial percentage uplift to the company’s annual revenue over the contract period while integrating into existing operations and maintaining gross profit margin profile.

MicroVision (NASDAQ:MVIS) agreed to acquire certain Luminar assets for a cash purchase price of $33 million, including IP and inventory for the Iris and Halo lidar sensors, key engineering and operations talent, and select commercial contracts and orders.The purchase followed a Section 363 auction in Luminar’s bankruptcy process. Closing is subject to customary conditions and bankruptcy court approval at a hearing on January 27, 2026, with completion expected on or shortly after February 2, 2026. Additional details will be provided on MicroVision’s next earnings call.

CNS Pharmaceuticals (NASDAQ:CNSP) issued a letter from newly appointed President and CEO Rami Levin outlining a strategic evaluation of the company on January 27, 2026. The CEO said the review covers the pipeline, development priorities, operations and capital allocation, with three guiding principles: Patients First, Pipeline Enrichment and Optimization, and Disciplined Value Creation. The company identified TPI 287 as its lead asset and core value driver and plans to refine clinical and regulatory strategies, prioritize indications, align with regulators and raise capital toward data and milestone achievements.

Anebulo Pharmaceuticals (Nasdaq: ANEB) announced preliminary results of its voluntary self-tender offer to purchase 300,000 shares of common stock at $3.50 per share, expiring January 26, 2026.Based on a preliminary count by the depositary, 4,897,188 shares were properly tendered (excluding 10,868 by guaranteed delivery), the offer was oversubscribed, and Anebulo expects to accept 300,000 shares pro rata for an aggregate cash cost of approximately $1.05 million (excluding fees).The preliminary proration factor is approximately 3.51542%, and the shares expected to be purchased represent about 0.73% of outstanding shares as of January 26, 2026; final numbers are subject to depositary confirmation.

Fortinet (FTNT) announced enhancements to FortiCNAPP on January 27, 2026 that unify network security posture, native Data Security Posture Management (DSPM), and runtime validation into a single cloud-risk workflow.The update adds network-aware risk scoring that factors FortiGate protection into workload exposure, in-place DSPM for data sensitivity and access visibility without moving data, and runtime-informed prioritization to distinguish theoretical from active risk, aiming to reduce alert noise and speed remediation across hybrid and multi-cloud environments.

AVAX One (NASDAQ: AVX) on Jan 27, 2026 released an investor presentation outlining its institutional onchain finance strategy and operating playbook. The presentation describes a regulated, institutional gateway to onchain finance built on the Avalanche blockchain, centered on disciplined AVAX accumulation, protocol-native staking, validator infrastructure, onchain yield generation, and a selective fintech acquisition framework targeting established, revenue-producing businesses with regulatory frameworks. The company says it will leverage Avalanche to improve efficiency, transparency and settlement while expanding long-term platform economics.

Foresight (NASDAQ:TASE: FRSX) said its majority-owned subsidiary Eye-Net advanced a multi-phase collaboration with SoftBank in Japan to further validate Eye-Net’s cellular-based V2X collision prediction and prevention technology.The initiative will tailor the solution to SoftBank’s needs, test real-time location exchange among road users, and evaluate potential introduction into new markets, aiming to improve situational awareness and reduce traffic incidents.